Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Completed 2Active not recruiting 2Withdrawn 1Not yet recruiting 1

Sponsor Class

OTHER 65INDUSTRY 17OTHER_GOV 3NIH 1NETWORK 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1Genitourinary 1Breast 1

Conditions

Melanoma 3Leukemia, Myeloid, Acute 3Carcinoma, Non-Small-Cell Lung 3Sarcoma, Kaposi 2Sarcoma, Alveolar Soft Part 2Prostatic Neoplasms 2Non-Muscle Invasive Bladder Neoplasms 2Lymphoma 2Colorectal Neoplasms 2Carcinoma, Renal Cell 2Breast Neoplasms 2Urinary Incontinence 1Urinary Bladder Neoplasms 1Triple Negative Breast Neoplasms 1Solid Tumor 1Skin Neoplasms 1Sarcoma, Synovial 1Sarcoma, Clear Cell 1Sarcoma 1Rhabdomyosarcoma 1Recurrence 1Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 1Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Pancreatic Neoplasms 1Neurofibrosarcoma 1Neoplasms 1Musculoskeletal Pain 1Multiple Myeloma 1Malignant Solid Neoplasm 1Lymphoma, Non-Hodgkin 1

Interventions

fludarabine 1Cyclophosphamide 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Not yet recruiting × NETWORK × Triple Negative Breast Neoplasms × Clear all
NCT07297667 2026-05-12

GCAR1, a Chimeric Antigen Receptor (CAR) T-CELL Therapy for Relapsed/Refractory GPNMB-Expressing Solid Tumours

Canadian Cancer Trials Group

Phase 1 Not yet recruiting
30 enrolled
BreastGenitourinarySarcoma

Carcinoma, Renal Cell, Sarcoma, Alveolar Soft Part, Triple Negative Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡